Due to unstable quality of raw herbs and obsolete production methods,
quality control of Traditional Chinese Medicine (TCM) has been an easy
target of criticisms from the conventional medical professionals. The
difficulties in identifying the ingredients as well as maintaining
consistency are formidable obstacles for all manufacturers who dare to
put their TCM products to the tests of international standards.
The United States Pharmacopeia (USP) is an official public
standards-setting authority for medicines and healthcare products in the
United States. USP's standards are recognized and used in more than 130
countries around the globe, and thus are often considered as one of the
world's highest quality standards for pharmaceutical products. PuraPharm
is the first manufacturer bold enough to put one of its flagship
products under the spotlight of USP. After two years of observations and corrective actions, professionals from USP were finally
convinced that the quality of a Chinese medicine ingredient could be
held to the same strict standards of western medicinal ingredient.
PuraPharm's ONCO-Z is thus officially engraved in history as the
absolute first USP verified TCM ingredient.
The message shocked the Chinese and western medical sectors, which
marked a significant breakthrough in the development of TCM.
A new chapter of traditional Chinese medicine has begun!
